摘要
目的:检测含补肾中药合剂血清对体外培养的人成骨细胞(hFOB 1.19)增殖的影响。方法:通过MTT分别评估低和高剂量含补肾中药血清中成骨细胞分化与增值的能力,BrdU标记法来评估药物血清对细胞增殖的影响。结果:人成骨细胞在含补肾中药血清中培养24h后细胞活力与对照组比较显著增加,有统计学意义(P<0.05);延长培养时间到48h后细胞生长活力进一步增强(P<0.05)。结论:含补肾中药合剂血清可明显促进成骨细胞的增殖。
Objective: To examine the effects of the kidney--reinforcing Chinese herbal medicated serum on the proliferation of human osteoblastic cells (hFOB 1.19) cultured in vitro. Methods: The MTT assay was used to eval- uate cell viability (under low and high doses), BrdU labeling was used to assess the effects of the medicated sera (48 h incubation) on cell proliferation. Results: Exposure of hFOB 1. 19 cells to the prepared medicated sera for 24 h significantly increased cell viability in comparison with the control group (P〈0.05). Extension of the incubation time to 48 h further augmented cell viability (P〈0.05) and growth appearance. Conclusion: The medicated sera of the kidney--reinforcing Chinese herbal mixture could significantly promote the proliferation of osteoblasts.
出处
《口腔医学研究》
CAS
CSCD
2012年第11期1100-1102,1106,共4页
Journal of Oral Science Research
基金
广东省中医药局立项资助课题(编号:20111264)
广州市荔湾区科技局立项资助课(编号:20111213053)
关键词
成骨细胞
增殖
中药合剂
种植体
Osteoblasts Proliferation Traditional chinese medicine mixture Dental implant